Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1173 of 5804
-
Could a daily postbiotic powder help cancer patients keep weight on?
Symptom relief Not yet recruitingThis study aims to evaluate the efficacy of the oral postbiotic preparation JK-5G in improving body weight among patients with non-small-cell lung cancer (NSCLC)-related cachexia. By means of a randomized controlled trial, we will compare the between-group difference in body-weig…
Phase: NA • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Higher aspirin dose may better prevent dangerous pregnancy condition
Prevention Not yet recruitingThis study aims to evaluate the effectiveness of 75 mg aspirin versus 150 mg aspirin in preventing preeclampsia among individuals with high risk for the condition. Existing literature suggests that the 150 mg aspirin dose may exhibit superior efficacy, yet inconclusive evidence e…
Phase: NA • Sponsor: Shalamar Hospital • Aim: Prevention
Last updated Jun 27, 2026 07:53 UTC
-
Timing is everything: new trial seeks to boost lung cancer treatment by rescheduling immunotherapy
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate whether individualized sequencing of immunotherapy and chemotherapy based on immune dynamics can improve treatment outcomes in adults with advanced non-small cell lung cancer (NSCLC) without driver gene mutations. This study will als…
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Robotic surgery showdown: which approach saves bladder control?
Disease control OngoingThis study was designed as a prospective, multicentre, double-blind, randomised controlled clinical trial. It aims to investigate the feasibility and safety of the posterior approach extrafascial technique and the anterior approach extrafascial technique in robot-assisted radical…
Phase: NA • Sponsor: Ning Xu • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could a plasma gel heal diabetic foot ulcers faster?
Disease control Recruiting nowThis study is a randomized clinical trial that compares the effectiveness of Plasma Rich in Growth Factors (PRGF) with conventional treatment for healing foot ulcers in diabetic patients who also have peripheral arterial disease. The goal is to assess how well PRGF promotes heali…
Phase: PHASE4 • Sponsor: Biotechnology Institute IMASD • Aim: Disease control
Last updated Jun 26, 2026 16:50 UTC
-
Can cannabis calm the brain? new study scans Veterans' brains for clues
Knowledge-focused ENROLLING_BY_INVITATIONThis study will be the first to use brain imaging to explore how cannabis affects the brain and inflammation in U.S. military veterans with PTSD. It builds on an ongoing study testing different combinations of THC and CBD in 200 veterans. In this project, up to 100 veterans will …
Sponsor: Wayne State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Can a doula help pregnant abuse survivors? new trial aims to find out
Symptom relief Recruiting nowThis is a two-armed, fully powered hybrid type 1 trial to test the effectiveness of a doula intervention compared with an active control in reducing intimate partner violence (IPV) among perinatal IPV survivors
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Could brain zaps wake the unresponsive? tiny trial begins
Disease control Recruiting nowThe RE-CONNECT study is an early feasibility study to establish the safety, feasibility, and efficacy of two central thalamic deep brain stimulation targets in patients with chronic disorders of consciousness.
Phase: EARLY_PHASE1 • Sponsor: Samuel Snider, MD • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
AI guides Doctors' lungs scope in pneumonia battle
Diagnosis Not yet recruitingThis study will evaluate an embodied-intelligence-assisted bronchoscopy navigation and diagnostic system for patients with severe pneumonia who require clinically indicated bronchoscopy. The system provides real-time visual cues and voice prompts to help physicians localize targe…
Phase: NA • Sponsor: Chinese Medical Association • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
New drug cocktail aims to tackle tough gut cancers
Disease control Not yet recruitingThis study is a multicenter, open-label, phase II clinical trial evaluating the combination of SSGJ-706 with standard therapy for advanced gastrointestinal tumors. Its objective is to assess the safety, tolerability, and antitumor activity of SSGJ-706 in combination with standard…
Phase: PHASE2 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could CT scans replace MRI for cervical cancer radiation? major study launches
Knowledge-focused Not yet recruitingTitle: Integration of Multi-modality Imaging Protocols with Emphasis on CT in Image-Guided Adaptive Brachytherapy (IGABT) for Cervical Cancer - EMBRACE III-TRIPLET : IMPACT Study Locally advanced cervical cancer (LACC) remains a major health challenge, particularly in low- and mi…
Sponsor: Homi Bhabha Cancer Hospital & Research Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
10,000-Patient trial tests smartphone app to manage diabetes with ancient and modern medicine
Disease control Recruiting nowThe management of diabetes is of great value in reducing the risk of complications and alleviating the socioeconomic burden. Currently, the diabetes management models in China have not effectively integrated the advantages of traditional Chinese medicine (TCM) and Western medicin…
Phase: NA • Sponsor: Shanxi Bethune Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Breathing trainer may delay ventilator need in ALS patients
Disease control Recruiting nowThe goal of this clinical trial is to learn whether lung insufflation capacity (LIC) training can help maintain respiratory function and prolong survival in people with amyotrophic lateral sclerosis (ALS). The main questions it aims to answer are: * Does early and continuous LI…
Phase: NA • Sponsor: National Center of Neurology and Psychiatry, Japan • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New hope for kidney transplants: drug targets hidden inflammation
Disease control OngoingThe DARA-MVI Study is a prospective, randomized, controlled, open-label trial designed to evaluate the effect of daratumumab on microvascular inflammation (MVI) in kidney transplant recipients with C4d-negative biopsies. Participants with biopsy-proven MVI will be randomized to r…
Phase: PHASE4 • Sponsor: University Hospital, Martin • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Heart attack patients may ditch aspirin sooner with new stent
Disease control Recruiting nowPrimary percutaneous coronary intervention (PCI) is the preferred revascularization strategy for patients with acute ST-segment elevation myocardial infarction (STEMI). Compared with bare-metal stents (BMS) and early-generation thick-strut polymer-based drug-eluting stents (DES),…
Phase: NA • Sponsor: IGLESIAS Juan Fernando • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New liquid embolic shows promise for prostate troubles
Disease control Not yet recruitingProstatic Artery Embolization (PAE) is a recognized mini-invasive treatment of bothersome Lower Urinary Tract Symptoms (LUTS) related to Benign Prostatic Hyperplasia (BPH). Particle embolics are used almost exclusively for embolization, with wide variation in the type and size of…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Simple Finger-Prick test could uncover hidden heart failure
Diagnosis ENROLLING_BY_INVITATIONThe goal of this clinical trial is to learn whether a simple blood test screening pathway can help diagnose heart failure earlier in adults in primary care who take loop diuretic medicines (such as furosemide or bumetanide) but do not have a recorded diagnosis of heart failure. …
Phase: NA • Sponsor: Government of Jersey • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Could a drug calm this rare muscle and lung disease?
Disease control Recruiting nowThe goal of this clinical trial is to learn if tocilizumab works to treat anti-MDA5+ dermatomyositis (anti-MDA5+DM) in adults. It will also learn about the safety of tocilizumab. The main questions it aims to answer are: Does tocilizumab improve patients' clinical symptoms? Does…
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug shows promise for repairing damaged hearts in stable heart failure patients
Disease control Recruiting nowThe goal of this clinical trial is to investigate how vericiguat benefits adults with stable heart failure with reduced ejection fraction (HFrEF) who are already receiving guideline-directed medical therapy. The main questions are: * Does vericiguat improve right ventricular sy…
Phase: PHASE4 • Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
AI could personalize liver cancer care after surgery
Knowledge-focused Recruiting nowHepatocellular carcinoma (HCC) is a high-mortality global malignancy with a heavy disease burden in China. Although curative surgical resection improves survival for early-stage HCC patients, the 5-year postoperative recurrence rate remains as high as 50%-70%. Postoperative adjuv…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC